# High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients

> **NCT07094724** · PHASE2 · RECRUITING · sponsor: **Gili Regev-Yochay MD** · enrollment: 37 (estimated)

## Conditions studied

- West Nile Fever

## Interventions

- **BIOLOGICAL:** Plasma

## Key facts

- **NCT ID:** NCT07094724
- **Lead sponsor:** Gili Regev-Yochay MD
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07094724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07094724, "High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07094724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*